Image

    Drug-Induced Gynecomastia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

    Alberto Trinchieri, Gianpaolo Perletti, Vittorio Magri … Emanuele Montanari
    Studysummary This review found that patients taking antiandrogens, 5 alpha-reductase inhibitors, and spironolactone have an increased risk of developing gynecomastia, potentially due to hormonal changes.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on pagepressjournals.org →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review American Journal of Clinical Dermatology · 2017
    2. The Effect of 5α-Reductase Inhibition with Dutasteride and Finasteride on Semen Parameters and Serum Hormones in Healthy Men The Journal of Clinical Endocrinology and Metabolism · 2007
    3. The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment Among Men with Benign Prostatic Hyperplasia The New England Journal of Medicine · 1998

    Related research 1

    1. Topical Antiandrogens in the Treatment of Male-Pattern Baldness Clinics in dermatology · 1988